Publication | Open Access

Novel benzothiazinones (BTOs) as allosteric modulator or substrate competitive inhibitor of glycogen synthase kinase 3β (GSK-3β) with cellular activity of promoting glucose uptake

BiochemistryMedicineInsulin ManagementDiabetesAllosteric ModulatorCellular PharmacologyNovel BenzothiazinonesMetabolic SignalingPharmacologyGlucose UptakeDrug DiscoveryInsulin Signaling